Roystone Management Holdings LLC bought $352K of biote (BTMD)
Executed Mar 31 2025, disclosed Apr 2 2025, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Apr 2 2025), the stock returned -7.9% (delay-adjusted); from the execution session (Mar 31 2025), +5.0%. Derived: entry at the session's open, exit at the close 20 sessions later.
Roystone Management Holdings LLC (10% owner) filed 1 Form 4 report as a reporting entity in the past 24 months (1 purchase, 0 sales), most often in biote Corp. (BTMD). Across 1 priced purchase filing, the average 21-session return was +5.0% from execution and -7.9% from disclosure (delay-adjusted; derived). The largest single filing was $352K of BTMD (106,000 sh × $3.32, as filed), executed Mar 31 2025.
Healthcare · biote Corp. operates in practice-building business within the hormone optimization space
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→